Free Trial

NLS Pharmaceutics (NLSPW) Competitors

NLS Pharmaceutics logo
$0.01 +0.00 (+0.71%)
As of 07/25/2025 12:56 PM Eastern

NLSPW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying NLS Pharmaceutics stock or one of its competitors? The main competitors of NLS Pharmaceutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

NLS Pharmaceutics vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and NLS Pharmaceutics (NASDAQ:NLSPW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings and risk.

In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.89 equaled NLS Pharmaceutics'average media sentiment score.

Company Overall Sentiment
180 Life Sciences Very Positive
NLS Pharmaceutics Very Positive

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
NLS Pharmaceutics N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
NLS PharmaceuticsN/AN/AN/AN/AN/A

Summary

180 Life Sciences and NLS Pharmaceutics tied by winning 0 of the 0 factors compared between the two stocks.

Get NLS Pharmaceutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NLSPW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NLSPW vs. The Competition

MetricNLS PharmaceuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$136.77M$5.70B$9.50B
Dividend YieldN/A3.74%4.58%4.01%
P/E RatioN/A3.7828.4120.08
Price / SalesN/A4,471.55432.3189.32
Price / CashN/A13.1936.2258.56
Price / BookN/A42.328.675.88
Net IncomeN/A-$90.99M$3.25B$258.89M
7 Day PerformanceN/A4.86%4.25%3.71%
1 Month PerformanceN/A8.36%10.51%11.72%
1 Year PerformanceN/A195.82%35.68%18.01%

NLS Pharmaceutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NLSPW
NLS Pharmaceutics
N/A$0.01
+0.7%
N/A-68.4%$0.00N/A0.006Positive News
ATNFW
180 Life Sciences
N/A$0.01
-6.3%
N/A+22.2%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
flat
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.14
+16.8%
N/A+95.0%$0.00$106.21K0.0040Gap Up
ALVOW
Alvotech
N/A$1.59
-3.6%
N/A-0.7%$0.00$585.60M0.004Gap Down
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.04
+75.5%
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.10
-11.4%
N/AN/A$0.00$38.00M0.0070Gap Down
BTMDW
biote
N/A$0.01
+20.0%
N/A-96.8%$0.00$199.38M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.03
-31.8%
N/A-78.1%$0.00N/A0.008Gap Down

Related Companies and Tools


This page (NASDAQ:NLSPW) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners